ARTICLE | Company News
Palatin other research news
October 7, 1996 7:00 AM UTC
PLTN received two $95,000 Phase I SBIR grants from NIH to develop peptide-based therapeutics and diagnostics based on PLTN's Midas peptide technology. The first grant will fund animal testing of a clo...